Sun Pharmaceuticals Industries Ltd Share Price – NSE  /  BSE

Pharmaceuticals, Mid Cap

Sun Pharmaceuticals Industries Ltd dropped for a fifth straight session today. The stock is quoting at Rs 1602.95, down 0.38% on the day as on 13:19 IST on the NSE. The benchmark NIFTY is up around 0.79% on the day, quoting at 22691.65. The Sensex is at 74853.29, up 0.81%.Sun Pharmaceuticals Industries Ltd has added around 0.59% in last one month.Meanwhile, Nifty Pharma index of which Sun Pharmaceuticals Industries Ltd is a constituent, has increased around 0.15% in last one month and is currently quoting at 19160.75, up 0.37% on the day. The volume in the stock stood at 5.96 lakh shares today, compared to the daily average of 27.95 lakh shares in last one month.

The benchmark April futures contract for the stock is quoting at Rs 1612.3, up 0.08% on the day. Sun Pharmaceuticals Industries Ltd jumped 58.93% in last one year as compared to a 28.75% rally in NIFTY and a 56.37% spurt in the Nifty Pharma index.

The PE of the stock is 93.72 based on TTM earnings ending December 23.

Powered by Capital Market - Live News

Sun Pharmaceuticals Industries Ltd rose for a third straight session today. The stock is quoting at Rs 1603.7, up 2.46% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.36% on the day, quoting at 22091.6. The Sensex is at 72819.71, up 0.25%. Sun Pharmaceuticals Industries Ltd has added around 2.72% in last one month.

Meanwhile, Nifty Pharma index of which Sun Pharmaceuticals Industries Ltd is a constituent, has added around 1.44% in last one month and is currently quoting at 18582.6, up 1.03% on the day. The volume in the stock stood at 28.78 lakh shares today, compared to the daily average of 22.53 lakh shares in last one month.

The benchmark March futures contract for the stock is quoting at Rs 1603.35, up 2.39% on the day. Sun Pharmaceuticals Industries Ltd is up 64.04% in last one year as compared to a 29.37% gain in NIFTY and a 59.35% gain in the Nifty Pharma index.

The PE of the stock is 91.12 based on TTM earnings ending December 23.

Powered by Capital Market - Live News

Sun Pharmaceutical Industries announced that the Australian Therapeutic Goods Administration (TGA) has granted regulatory approval for Winlevi® (clascoterone cream 1%).

Winlevi® is indicated for the topical treatment of acne vulgaris in patients 12 years of age and older.

As stated by Hellen de Kloet, Business Head – Western Europe, Australia and New Zealand, Sun Pharma “Winlevi® is an exciting addition to our expanding dermatology portfolio of innovative medicines in Australia. Winlevi's novel mechanism of action will be a welcome addition to the physician's toolkit while treating acne.”

Diana Harbort, President of the Dermatology Division of Cosmo, said: “We are very pleased that Winlevi® will soon be available to patients in Australia. This is another achievement in the mission of Cosmo and Sun Pharma to improve the lives of patients affected by skin conditions.”

Winlevi® will be available in Australia this June.

Powered by Capital Market - Live News

Sun Pharmaceuticals Industries Ltd gained for a fifth straight session today. The stock is quoting at Rs 1618.85, up 0.82% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is down around 0.37% on the day, quoting at 22411.2. The Sensex is at 73794.19, down 0.44%. Sun Pharmaceuticals Industries Ltd has risen around 5.5% in last one month.

Meanwhile, Nifty Pharma index of which Sun Pharmaceuticals Industries Ltd is a constituent, has risen around 3.5% in last one month and is currently quoting at 19194.1, up 0.67% on the day. The volume in the stock stood at 11.47 lakh shares today, compared to the daily average of 21.47 lakh shares in last one month.

The benchmark March futures contract for the stock is quoting at Rs 1621.3, up 0.79% on the day. Sun Pharmaceuticals Industries Ltd is up 69.67% in last one year as compared to a 30.64% spurt in NIFTY and a 66.62% spurt in the Nifty Pharma index.

The PE of the stock is 93.57 based on TTM earnings ending December 23.

Powered by Capital Market - Live News